1. Home
  2. SYBX vs EEIQ Comparison

SYBX vs EEIQ Comparison

Compare SYBX & EEIQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYBX
  • EEIQ
  • Stock Information
  • Founded
  • SYBX N/A
  • EEIQ 2017
  • Country
  • SYBX United States
  • EEIQ United States
  • Employees
  • SYBX N/A
  • EEIQ N/A
  • Industry
  • SYBX Biotechnology: Pharmaceutical Preparations
  • EEIQ Other Consumer Services
  • Sector
  • SYBX Health Care
  • EEIQ Real Estate
  • Exchange
  • SYBX Nasdaq
  • EEIQ Nasdaq
  • Market Cap
  • SYBX 17.0M
  • EEIQ 13.8M
  • IPO Year
  • SYBX N/A
  • EEIQ 2021
  • Fundamental
  • Price
  • SYBX $1.42
  • EEIQ $1.06
  • Analyst Decision
  • SYBX Hold
  • EEIQ
  • Analyst Count
  • SYBX 3
  • EEIQ 0
  • Target Price
  • SYBX $1.00
  • EEIQ N/A
  • AVG Volume (30 Days)
  • SYBX 74.6K
  • EEIQ 113.1K
  • Earning Date
  • SYBX 11-12-2024
  • EEIQ 01-06-2025
  • Dividend Yield
  • SYBX N/A
  • EEIQ N/A
  • EPS Growth
  • SYBX N/A
  • EEIQ N/A
  • EPS
  • SYBX N/A
  • EEIQ N/A
  • Revenue
  • SYBX $2,777,000.00
  • EEIQ $6,454,461.00
  • Revenue This Year
  • SYBX N/A
  • EEIQ N/A
  • Revenue Next Year
  • SYBX N/A
  • EEIQ N/A
  • P/E Ratio
  • SYBX N/A
  • EEIQ N/A
  • Revenue Growth
  • SYBX 292.23
  • EEIQ 13.32
  • 52 Week Low
  • SYBX $1.22
  • EEIQ $0.60
  • 52 Week High
  • SYBX $5.12
  • EEIQ $2.10
  • Technical
  • Relative Strength Index (RSI)
  • SYBX 48.54
  • EEIQ 61.42
  • Support Level
  • SYBX $1.36
  • EEIQ $0.94
  • Resistance Level
  • SYBX $1.88
  • EEIQ $1.17
  • Average True Range (ATR)
  • SYBX 0.09
  • EEIQ 0.10
  • MACD
  • SYBX -0.01
  • EEIQ -0.00
  • Stochastic Oscillator
  • SYBX 11.54
  • EEIQ 68.57

About SYBX Synlogic Inc.

Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.

About EEIQ EpicQuest Education Group International Limited

EpicQuest Education Group International Ltd provides comprehensive education solutions for domestic and international students interested in university and college degree programs in the U.S., Canada, and the UK. In addition, the company has a recruiting relationship with the regional campuses of Miami University of Ohio, where it maintains residential facilities, a full-service cafeteria, recreational facilities, shuttle buses, and an office for the regional campuses that provides study abroad and post-study services for its students; these facilities are not owned, maintained, operated or are part of Miami University.

Share on Social Networks: